11/20
06:02 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/20
06:02 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
11:43 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/18
11:43 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/18
09:00 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/18
09:00 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/17
04:15 pm
rvmd
Revolution Medicines initiated with an Outperform at Wolfe Research
Low
Report
Revolution Medicines initiated with an Outperform at Wolfe Research
11/17
04:15 pm
rvmd
Revolution Medicines initiated with an Outperform at Wolfe Research
Low
Report
Revolution Medicines initiated with an Outperform at Wolfe Research
11/6
04:13 pm
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/6
08:35 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
11/6
08:35 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
11/6
08:18 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
11/6
08:18 am
rvmd
Rating for RVMD
Medium
Report
Rating for RVMD
11/3
09:17 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/3
09:17 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
11/3
09:03 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $77.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $77.00 price target on the stock.
11/3
09:03 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $77.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $77.00 price target on the stock.
11/3
05:28 am
rvmd
Revolution Medicines initiated with an Outperform at RBC Capital
Low
Report
Revolution Medicines initiated with an Outperform at RBC Capital
11/3
05:28 am
rvmd
Revolution Medicines initiated with an Outperform at RBC Capital
Low
Report
Revolution Medicines initiated with an Outperform at RBC Capital
10/23
06:16 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Mizuho to a "strong-buy" rating.
10/23
06:16 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Mizuho to a "strong-buy" rating.
10/21
08:44 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/21
08:44 am
rvmd
Rating for RVMD
Low
Report
Rating for RVMD
10/21
08:03 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Mizuho. They set an "outperform" rating and a $90.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Mizuho. They set an "outperform" rating and a $90.00 price target on the stock.
10/21
08:03 am
rvmd
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Mizuho. They set an "outperform" rating and a $90.00 price target on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Mizuho. They set an "outperform" rating and a $90.00 price target on the stock.